Lilly awaits U.K. decision this week on Prozac for children

Eli Lilly will be watching closely this week while British regulators decide whether to make the company's Prozac the first anti-depressant drug approved in the U.K. for children, as it is in the U.S. The U.K. regulators have had their eye on fluoxetine, the generic name of Prozac, for nearly a year as one drug for youths that would not lead them to consider suicide and one in which the benefits outweigh the risks.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA